Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline

Coronavirus vaccine developer Moderna Inc held a virtual R&D event Thursday, showcasing its portfolio and key therapeutic areas.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.